PATENT CLAIM ANALYSIS

Application Number: 16026658
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "489000"]

Abstract:
The present invention relates to a pharmaceutical composition comprising deferasirox, a process for preparing such pharmaceutical composition, and its use in the treatment of chronic iron overload. The pharmaceutical composition comprises nanosized deferasirox having improved surface area and solubility. It also relates to a method for treatment of chronic iron overload which comprises administering a pharmaceutical composition comprising nanosized deferasirox.

Claim (Index 9):
A pharmaceutical composition according to  claim 7 , wherein the pharmaceutically acceptable carrier comprises: one or more diluents or fillers; one or more binders; one or more lubricants; one or more glidants; one or more disintegrants; one or more preservatives; one or more humectants; one or more solution retarders; one or more absorption accelerators; one or more wetting agents; one or more adsorbents; one or more buffering agents; or a mixture thereof.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 95.0
- Lexical Diversity: 1.71053
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15185888', '10444066', '11568692', '11402264', '14198872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7595323465067454
- 35 USC 102 Novelty (BERT): 0.5063033418920245
- Combined Prediction Score: 0.7342094460452734
- Mean Citation Score: 235.369036
- Max Citation Score: 248.36891
- Similarity Product: 163.2667991102719

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test